Skip to content

Fundus-first Laparoscopic Cholecystectomy

Fundus-first Laparoscopic Cholecystectomy in Difficult Gallbladder

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07137546
Acronym
FFLC
Enrollment
174
Registered
2025-08-22
Start date
2024-05-01
Completion date
2026-02-17
Last updated
2026-02-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Cholecystitis, Cholecystitis, Pericholecystic Abscess

Keywords

Fundus-first laparoscopic cholecystectomy, Conventional laparoscopic cholecystectomy, Bile duct injury, Difficult gallbladder, Critical view of safety

Brief summary

Bile duct injury (BDI) remains the most feared complication of laparoscopic cholecystectomy, particularly in difficult gallbladder cases. The fundus-first technique has emerged as a potentially safer alternative to classical laparoscopic cholecystectomy for challenging cases. This single-center, prospective, randomized controlled trial compared the efficacy and safety of fundus-first laparoscopic cholecystectomy (FF-LC) versus classical laparoscopic cholecystectomy (C-LC) in 174 patients with difficult gallbladder characteristics. The primary outcome was bile duct injury rate. Secondary outcomes included conversion to open surgery, operative parameters, and postoperative complications.

Detailed description

Bile duct injury (BDI) rates remain 0.3-1.5% in difficult gallbladders. FFLC avoids early dissection near critical structures, potentially lowering BDI risk. This randomized controlled trial aims to compare the safety and efficacy of fundus-first (FF) versus classical (Calot-first) laparoscopic cholecystectomy techniques in patients with difficult gallbladders. The study will evaluate perioperative outcomes, conversion rates, complications, and operative time between the two surgical approaches. Based on recent evidence suggesting an improved safety profile with the fundus-first technique, we hypothesize that the FF approach will demonstrate reduced bile duct injury rates and improved surgical outcomes in difficult cases.

Interventions

PROCEDUREFundus-First Laparoscopic Cholecystectomy ( FFLC)

* Standard 4-port laparoscopic setup * Carbon dioxide (CO₂) pneumoperitoneum (12-15 mmHg) * Dissection begins at gallbladder fundus * Peritoneum incised from infundibulum to fundus along liver bed * Gallbladder dissected from fundus toward infundibulum * Cystic artery and duct identified and divided last * Critical view of safety achieved before vessel division

PROCEDUREClassical Laparoscopic Cholecystectomy (CLC)

* Standard 4-port laparoscopic setup * Carbon dioxide (CO₂) pneumoperitoneum (12-15 mmHg) * Dissection begins at Calot's triangle * Critical view of safety achieved first * Cystic artery and duct divided before gallbladder bed dissection * Gallbladder dissected from liver bed

Sponsors

Minia University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Masking description

Surgeons are not blinded due to the intervention's nature; data collectors, assessors, and analysts are blinded.

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Age 18-80 years * Symptomatic cholelithiasis or cholecystitis requiring laparoscopic cholecystectomy (elective or emergency) * Difficult gallbladder characteristics: Acute cholecystitis (Tokyo Guidelines 2018 Grade II/III), wall thickness \>4 mm on US, pericholecystic fluid, impacted stone in Hartmann's pouch/cystic duct, previous upper abdominal surgery, BMI \>30 kg/m², ≥3 previous cholecystitis episodes, contracted gallbladder, Mirizzi syndrome Type I/II, empyema, severe pericholecystic adhesions on imaging, suspected anatomical variations * The American Society of Anesthesiologists (ASA) physical status I-III * Suitable for laparoscopic approach * Informed consent

Exclusion criteria

* Suspected gallbladder malignancy * Choledocholithiasis requiring endoscopic intervention * Mirizzi syndrome Grade III-IV * Gallbladder perforation with generalized peritonitis * Pregnancy or lactation * Contraindications to laparoscopy (severe cardiopulmonary disease, coagulopathy) * Previous biliary or hepatic surgery * Cirrhosis with portal hypertension * Active coagulopathy * Patient refusal

Design outcomes

Primary

MeasureTime frameDescription
Bile Duct Injury RateIntraoperative to 30 days postoperativeIncidence of bile duct injury, confirmed by intraoperative cholangiography, direct visualization, or postoperative imaging.

Secondary

MeasureTime frameDescription
Intraoperative Cholangiography RateIntraoperativeProportion requiring cholangiography for unclear anatomy or suspected stones.
Gallbladder Perforation RateIntraoperativeIncidence of intraoperative gallbladder perforation.
Conversion to Open Surgery RateIntraoperativeRate of conversion from laparoscopic to open procedure due to dense adhesions, bleeding, unclear anatomy, or suspected BDI.
Operative TimeIntraoperativeTotal time from skin incision to closure (minutes).
Time to Achieve Critical View of Safety (CVS)IntraoperativeTime from incision to CVS achievement (minutes).
Estimated Blood LossIntraoperativeIntraoperative blood loss (mL).
CVS Achievement RateIntraoperativeProportion of cases where CVS was achieved.

Countries

Egypt

Contacts

PRINCIPAL_INVESTIGATORSaleh K Saleh, MD

Minia University

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 20, 2026